Vericel Corp·4

Oct 2, 4:05 PM ET

SIEGAL JONATHAN 4

4 · Vericel Corp · Filed Oct 2, 2025

Insider Transaction Report

Form 4
Period: 2025-09-30
SIEGAL JONATHAN
Principal Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-09-30$31.47/sh370$11,6442,070 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-09-30+9380 total
    Common Stock (938 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-30+9382,440 total
Footnotes (6)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021.
  • [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
  • [F4]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
  • [F5]No expiration date for this type of award.
  • [F6]The Fair Market Value of the vested derivative securities is $31.47 per share.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4